Pharma Journalist -

Following on from last year’s successful meeting, the 3rd RNA- Targeted Drug Discovery returns this December to unite 100+ key opinion leaders with expert insights for a unique,…
Read More...

Zucara Therapeutics Inc. a diabetes life sciences company developing the first once-daily therapeutic to prevent insulin-induced hypoglycemia (low blood glucose levels), announced that…
Read More...

TFF Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, and Augmenta Bioworks, Inc., a biotechnology company enabling breakthroughs in medicine through immune profiling,…
Read More...

Telix Pharmaceuticals Limited announces it has entered into a strategic licence and commercial partnership with China Grand Pharmaceutical and Healthcare Holdings Limited (‘China Grand…
Read More...

Biogen and Eisai, Co., Ltd. announced that the European Medicines Agency (EMA) has confirmed it has accepted for review, following a standard timetable, the Marketing Authorization…
Read More...

Sanofi and Kiadis, a clinical-stage biopharmaceutical company developing innovative ‘off the shelf’ natural killer (NK) cell based medicines for the treatment of life-threatening…
Read More...

SMi Reports: speaker session with Bjørg Kaae Hunter, Department Manager, RA CMC & Device, Novo Nordisk at Pre-filled Syringes and Injectable Drug Devices Conference 2021. Now in…
Read More...

SMi Reports: Registration is open for Europe’s only Parallel Trade virtual conference: online access only, taking place 22nd – 23rd March as a virtual conference. In light of on-going…
Read More...

Novartis announced that the European Commission (EC) has approved Adakveo (crizanlizumab) for the prevention of recurrent vaso-occlusive crises (VOCs), or pain crises, in patients with…
Read More...

Protagonist Therapeutics, Inc. announced that two additional oral peptide IL-23 receptor antagonist candidates from its collaboration agreement with Janssen Biotech, Inc., have been…
Read More...